will fda ban compounded semaglutide announces for weight loss drugs September 2, 2025: U.S. compounding
Description
That narrative has proven powerful
None of that, however, converts theory into established fact
During the first year after treatment began, 27.0% of patients reduced their BMI by less than 5%, 22.4% lost between 5% and less than 10%, 14.1% lost between 10% and less than 15%, and 15.8% reduced BMI by at least 15%
And then the questions start rolling in
